Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026)

Integer Holdings (ITGR) reported Cash from Investing Activities of -$37.9 million for Q2 2026, up 80.78% on a YoY basis from -$21.0 million in Q2 2025, and down 6.86% sequentially from -$35.5 million in Q4 2025.

Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Integer Holdings (ITGR) has 17 years of Cash from Investing Activities data on file, last reported at -$37.9 million in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities rose 80.78% year-over-year to -$37.9 million; the trailing twelve-month figure through Apr 2026 stood at -$111.5 million (up 50.32% YoY), and the FY2025 full-year result was -$270.7 million, down 38.54% from the prior year.
  • Cash from Investing Activities retreated to -$37.9 million in Q2 2026, from -$35.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $29.6 million in Q4 2024 to a low of -$197.2 million in Q1 2025.
  • A 5-year average of -$51.0 million and a median of -$30.6 million in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities tumbled 1185.43% in 2022 and surged 136.75% in 2024, its largest moves.
  • Tracing ITGR's Cash from Investing Activities over 5 years: stood at -$31.3 million in 2022, then sank by 157.26% to -$80.6 million in 2023, then jumped by 136.75% to $29.6 million in 2024, then sank by 219.76% to -$35.5 million in 2025, then decreased by 6.86% to -$37.9 million in 2026.
  • Business Quant data shows ITGR's Cash from Investing Activities at -$37.9 million in Q2 2026, -$35.5 million in Q4 2025, and -$20.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -20.32 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -185.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -92.80 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -298.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -475.32 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -2.50 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Integer Holdings 3.34 Bn 3.33 Bn 109.60 Mn -37.90 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -37.90 Mn
Apr 3, 2026 -37.90 Mn
Dec 31, 2025 -35.47 Mn
Dec 31, 2025 -35.47 Mn
Sep 26, 2025 -20.27 Mn
Sep 26, 2025 -20.27 Mn
Jun 27, 2025 -17.83 Mn
Jun 27, 2025 -17.83 Mn
Mar 28, 2025 -197.17 Mn
Mar 28, 2025 -197.17 Mn
Dec 31, 2024 29.62 Mn
Dec 31, 2024 29.62 Mn
Sep 27, 2024 -26.24 Mn
Sep 27, 2024 -26.24 Mn
Jun 28, 2024 -30.60 Mn
Jun 28, 2024 -30.60 Mn
Mar 29, 2024 -168.20 Mn
Mar 29, 2024 -168.20 Mn
Dec 31, 2023 -80.58 Mn
Dec 31, 2023 -80.58 Mn